Organizational Diversity among Distinct Glycoprotein Endoplasmic Reticulum-associated Degradation Programs
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Protein folding and quality control in the early secretory pathway function as posttranslational checkpoints in eukaryote gene expression. Herein, an aberrant form of the hepatic secretory protein α1-antitrypsin was stably expressed in a human embryonic kidney cell line to elucidate the mechanisms by which glycoprotein endoplasmic reticulum-associated degradation (GERAD) is administered in cells from higher eukaryotes. After biosynthesis, genetic variant PI Z underwent alternative phases of secretion and degradation, the latter of which was mediated by the proteasome. Degradation required release from calnexin- and asparagine-linked oligosaccharide modification by endoplasmic reticulum mannosidase I, the latter of which occurred as PI Z was bound to the molecular chaperone grp78/BiP. That a distinct GERAD program operates in human embryonic kidney cells was supported by the extent of PI Z secretion, apparent lack of polymerization, inability of calnexin to participate in the degradation process, and sequestration of the glycoprotein folding sensor UDP-glucose:glycoprotein glucosyltransferase in the Golgi complex. Because UDP-glucose:glycoprotein glucosyltransferase sustains calnexin binding, its altered distribution is consistent with a GERAD program that hinders the reentry of substrates into the calnexin cycle, allowing grp78/BiP to partner with a lectin, other than calnexin, in the recognition of a two-component GERAD signal to facilitate substrate recruitment. How the processing of a mutant protein, rather than the mutation itself, can contribute to disease pathogenesis, is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 2×
“To determine whether the multicatalytic system contributes to the turnover of PI Z in HEK/Z1, the pulse-radiolabeled molecules were subjected to a 5-h chase in medium containing 0.025 mM lactacystin, an irreversible covalent inhibitor of the proteasome (Fenteany et al., 1995).”
BackgroundMethodInfluentialHammond, C., Braakman, I., & Helenius, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.913 · Cited by 841 · cited 6×
“Conformational maturation abolishes recognition by UGT (Sousa et al., 1992), ensuring that native glycoproteins are released from the calnexin cycle and transported to the Golgi complex (Hammond et al., 1994).”
BackgroundInfluentialHtm1p, a mannosidase‐like protein, is involved in glycoprotein degradation in yeast
Jakob, C. A., Bodmer, D., Spirig, U., Bättig, P., Marcil, A., Dignard, D., Bergeron, J. J. M., Thomas, D. Y., & Aebi, M. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve089 · Cited by 252 · cited 2×
“implicated for its yeast homologs Htm1p (Jakob et al., 2001)”
BackgroundDissecting glycoprotein quality control in the secretory pathway
Cabral, C. M., Liu, Y., & Sifers, R. N. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01942-9 · Cited by 230 · cited 8×
“, noncarbohydrate) GERAD signal component (Cabral et al., 2001).”
BackgroundInfluentialSelf-citationParodi, A. J., Mendelzon, D. H., & Lederkremer, G. Z. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82057-2 · Cited by 86
Cited by
In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases
Hebert, D. N., & Molinari, M. (2007) · Physiological Reviews · doi:10.1152/physrev.00050.2006 · Cited by 671
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells
Rashid, S. T., Corbineau, S., Hannan, N., Marciniak, S. J., Miranda, E., Alexander, G., Huang-Doran, I., Griffin, J., Ahrlund-Richter, L., Skepper, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43122 · Cited by 606
EDEM As an Acceptor of Terminally Misfolded Glycoproteins Released from Calnexin
Oda, Y., Hosokawa, N., Wada, I., & Nagata, K. (2003) · Science · doi:10.1126/science.1079181 · Cited by 453
Quality Control and Protein Folding in the Secretory Pathway
Trombetta, E. S., & Parodi, A. J. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.110701.153949 · Cited by 422
Guerriero, C. J., & Brodsky, J. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00027.2011 · Cited by 418
Greene, C. M., Marciniak, S. J., Teckman, J., Ferrarotti, I., Brantly, M. L., Lomas, D. A., Stoller, J. K., & McElvaney, N. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.51 · Cited by 324
N-glycan structure dictates extension of protein folding or onset of disposal
Molinari, M. (2007) · Nature Chemical Biology · doi:10.1038/nchembio880 · Cited by 300
N-glycan processing in ER quality control
Ruddock, L. W., & Molinari, M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03225 · Cited by 300
Brostrom, M. A., & Brostrom, C. O. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00127-1 · Cited by 197
Molinari, M., Galli, C., Vanoni, O., Arnold, S. M., & Kaufman, R. J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.027 · Cited by 121
Glenn, K. A., Nelson, R. F., Wen, H. M., Mallinger, A. J., & Paulson, H. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709508200 · Cited by 86
Metadata
- Authors
- Cabral, C. M., Liu, Y., Moremen, K. W., & Sifers, R. N.
- Venue
- Molecular Biology of the Cell
- Published
- 2002-08
- Volume
- 13
- Issue
- 8
- Pages
- 2639-2650
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W2168009511
- Cited by
- 109
- References
- 6
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.